or Try an Advanced Search...

    Male Sexual Dysfunction Stocks List

    Symbol Grade Name % Change
    PTN D Palatin Technologies, Inc. -3.23
    AMPE F Ampio Pharmaceuticals, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biopharmaceutical Dysfunction Sexual Dysfunction Antioxidant Autoimmune Disease Cancer Clinical Development Diabetes Diabetic Macular Edema Diabetic Nephropathy Diabetic Retinopathy Diagnostic Products Disease Drug Development Endocrine System Eye Eye Diseases Healthcare Facilities Inflammation Inflammation Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Male Sexual Dysfunction stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.0
    View all Male Sexual Dysfunction ETFs...
    Compare ETFs

        Male Sexual Dysfunction Stocks Recent News

        Date Stock Title
        Oct 31 PTN Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biopharmaceutical Dysfunction Sexual Dysfunction Antioxidant Autoimmune Disease Cancer Clinical Development Diabetes Diabetic Macular Edema Diabetic Nephropathy Diabetic Retinopathy Diagnostic Products Disease Drug Development Endocrine System Eye Eye Diseases Healthcare Facilities Inflammation Inflammation Diseases
        Male Sexual Dysfunction

        Male Sexual Dysfunction is a condition in which a man is unable to perform sexually or has difficulty performing sexually. It can be caused by physical, psychological, or medical issues. Symptoms may include difficulty getting or maintaining an erection, decreased libido, premature ejaculation, or an inability to reach orgasm. Treatment options may include medications, lifestyle changes, counseling, or surgery.

        Browse All Tags